Compumedics Ltd Market Cap ($33.92 Million)
Market Cap & Net Worth: Compumedics Ltd (CMP)
Compumedics Ltd market cap. Compumedics Ltd (AU:CMP) has a market capitalization of $33.92 Million (AU$47.94 Million) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #23097 globally and #844 in its home market, demonstrating a 2.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Compumedics Ltd's stock price AU$0.24 by its total outstanding shares 199761754 (199.76 Million). Also see Compumedics Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Compumedics Ltd Market Cap History (2015–2026)
Compumedics Ltd market cap history from 2015 to 2026. Data shows change from $55.83 Million to $33.92 Million (-3.35% CAGR). Check latest Compumedics Ltd stock price today for real-time trading data and today's change.
Compumedics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Compumedics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CMP net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.93x
Compumedics Ltd's market cap is 0.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $122.97 Million | $37.54 Million | $3.27 Million | 3.28x | 37.57x |
| 2017 | $59.36 Million | $34.42 Million | $1.30 Million | 1.72x | 45.49x |
| 2018 | $56.54 Million | $37.00 Million | $2.78 Million | 1.53x | 20.31x |
| 2019 | $113.08 Million | $41.51 Million | $4.02 Million | 2.72x | 28.16x |
| 2020 | $70.67 Million | $35.07 Million | -$5.84 Million | 2.02x | N/A |
| 2021 | $52.30 Million | $35.74 Million | $998.00K | 1.46x | 52.40x |
| 2022 | $28.27 Million | $37.76 Million | $1.36 Million | 0.75x | 20.83x |
| 2023 | $39.58 Million | $42.41 Million | -$6.12 Million | 0.93x | N/A |
| 2024 | $37.46 Million | $49.72 Million | -$338.00K | 0.75x | N/A |
| 2025 | $47.35 Million | $51.04 Million | -$1.27 Million | 0.93x | N/A |
Competitor Companies of CMP by Market Capitalization
Companies near Compumedics Ltd in the global market cap rankings as of November 7, 2026. Also see CMP asset base for a full breakdown of the balance sheet.
Key companies related to Compumedics Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Compumedics Ltd (2015–2026)
Market capitalization of Compumedics Ltd from 2015 to today. Between 2015 and today, Compumedics Ltd's market cap moved from $55.83 Million to $ 33.92 Million, with a yearly change of -3.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$33.92 Million | -28.36% |
| 2025 | AU$47.35 Million | +26.42% |
| 2024 | AU$37.46 Million | -5.36% |
| 2023 | AU$39.58 Million | +40.00% |
| 2022 | AU$28.27 Million | -45.95% |
| 2021 | AU$52.30 Million | -26.00% |
| 2020 | AU$70.67 Million | -37.50% |
| 2019 | AU$113.08 Million | +100.00% |
| 2018 | AU$56.54 Million | -4.76% |
| 2017 | AU$59.36 Million | -51.72% |
| 2016 | AU$122.97 Million | +120.25% |
| 2015 | AU$55.83 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Compumedics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.92 Million USD |
| MoneyControl | $33.92 Million USD |
| MarketWatch | $33.92 Million USD |
| marketcap.company | $33.92 Million USD |
| Reuters | $33.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more